Pfizer CEO Albert Bourla says his company's anti-viral pill to treat Covid-19 awaiting FDA approval could be a game-changer in fighting the pandemic, but cautioned that it should not replace vaccines because the goal is to not get infected by the coronavirus in the first place.
